7.7 C
Saturday, May 8, 2021

Covaxin “found to neutralize variant 617”: Anthony Fauci, US health expert

Must read

UK Time Newshttps://www.uktimenews.com
UK Time News is your daily dose of Latest News, Entertainment, Music, Fashion, Lifestyle, World, Cricket, Sports, Politics, Tech, Business News Website. We provide you with the Latest Breaking News Straight from the UK & all around the World on different categories.

Covaxin was found to neutralize Covid variant 617, said Anthony Fauci (File)

New Delhi:

Covaxin, the Covid vaccine grown in India and produced by Bharat Biotech, has been shown to neutralize variant B.1.617 or the Indian double mutant strain, House chief medical adviser Anthony Fauci said on Tuesday.

“This is something that we still get data on on a daily basis. But the most recent data involved sera recovering from COVID-19 cases and people who had received the vaccine used in India, Covaxin. It was found to neutralize the 617 variant, ”he said, according to the PTI news agency.

READ  Temporarily shutting down India to end COVID-19 transmission cycle: Anthony Fauci
READ  Are Sweden's COVID Freedoms Costing Lives? | UKTN | 04.21.2021

“So despite the real difficulty that we are seeing in India, vaccination could be a very, very important antidote to this,” Dr Fauci told reporters.

Covaxin was developed by Bharat Biotech in partnership with the National Institute of Virology and the Indian Council for Medical Research (ICMR) and was approved for emergency use on January 3 while it was still in a clinical trial.

The results of the trials later showed that the vaccine was 78% effective, according to the ICMR.

The B.1.617 variant, mainly found in Covid cases in Maharashtra and Delhi, has three new peak protein mutations. This variant is said to push the deadly second wave of Covid across the country.

READ  Serious and rare

Covaxin uses dead viruses and works by teaching the immune system to make antibodies against the coronavirus. When Covaxin is given, immune cells recognize the dead virus, which prompts the immune system to make antibodies to fight the coronavirus.

WHO told B.1.617 on Tuesday that a variant of Covid-19 feared to contribute to an increase in coronavirus cases in India had been found in more than a dozen countries.

READ  US to consider sending AstraZeneca vaccine to Covid-Hit India: Top Expert

The United Nations health agency said the B.1.617 variant of Covid-19 first found in India was detected on Tuesday in more than 1,200 footage uploaded to “GISAID’s open-access database” at least 17 countries “.

READ  Temporarily shutting down India to end COVID-19 transmission cycle: Anthony Fauci

“Most of the footage was uploaded from India, UK, US and Singapore,” the WHO said in its weekly epidemiological update on the pandemic.

WHO recently classified B.1.617 as a “variant of interest” and said it has been found in 17 countries.

Covid cases in India broke a new record today with 3.6 lakh cases and more than 3,000 deaths in 24 hours.


More articles


Latest article